Literature DB >> 12601110

Clinical course correlates poorly with muscle pathology in nemaline myopathy.

M M Ryan1, B Ilkovski, C D Strickland, C Schnell, D Sanoudou, C Midgett, R Houston, D Muirhead, X Dennett, L K Shield, U De Girolami, S T Iannaccone, N G Laing, K N North, A H Beggs.   

Abstract

OBJECTIVE: To report pathologic findings in 124 Australian and North American cases of primary nemaline myopathy.
METHODS: Results of 164 muscle biopsies from 124 Australian and North American patients with primary nemaline myopathy were reviewed, including biopsies from 19 patients with nemaline myopathy due to alpha-actin (ACTA1) mutations and three with mutations in alpha-tropomyosin(SLOW) (TPM3). For each biopsy rod number per fiber, percentage of fibers with rods, fiber-type distribution of rods, and presence or absence of intranuclear rods were documented.
RESULTS: Rods were present in all skeletal muscles and diagnosis was possible at all ages. Most biopsies contained nemaline bodies in more than 50% of fibers, although rods were seen only on electron microscopy in 10 patients. Rod numbers and localization correlated poorly with clinical severity. Frequent findings included internal nuclei and increased fiber size variation, type 1 fiber predominance and atrophy, and altered expression of fiber type specific proteins. Marked sarcomeric disruption, increased glycogen deposition, and intranuclear rods were associated with more severe clinical phenotypes. Serial biopsies showed progressive fiber size variation and increasing numbers of rods with time. Pathologic findings varied widely in families with multiple affected members.
CONCLUSIONS: Very numerous nemaline bodies, glycogen accumulation, and marked sarcomeric disruption were common in nemaline myopathy associated with mutations in skeletal alpha-actin. Nemaline myopathy due to mutations in alpha-tropomyosin(SLOW) was characterized by preferential rod formation in, and atrophy of, type 1 fibers. Light microscopic features of nemaline myopathy correlate poorly with disease course. Electron microscopy may correlate better with disease severity and genotype.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12601110     DOI: 10.1212/01.wnl.0000046585.81304.bc

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  34 in total

1.  Knockin mouse model of the human CFL2 p.A35T mutation results in a unique splicing defect and severe myopathy phenotype.

Authors:  Samantha M Rosen; Mugdha Joshi; Talia Hitt; Alan H Beggs; Pankaj B Agrawal
Journal:  Hum Mol Genet       Date:  2020-07-29       Impact factor: 6.150

2.  Mutations and polymorphisms of the skeletal muscle alpha-actin gene (ACTA1).

Authors:  Nigel G Laing; Danielle E Dye; Carina Wallgren-Pettersson; Gabriele Richard; Nicole Monnier; Suzanne Lillis; Thomas L Winder; Hanns Lochmüller; Claudio Graziano; Stella Mitrani-Rosenbaum; Darren Twomey; John C Sparrow; Alan H Beggs; Kristen J Nowak
Journal:  Hum Mutat       Date:  2009-09       Impact factor: 4.878

3.  Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscle.

Authors:  Despina Sanoudou; Judith N Haslett; Alvin T Kho; Shaoqiang Guo; Hanna T Gazda; Steven A Greenberg; Hart G W Lidov; Isaac S Kohane; Louis M Kunkel; Alan H Beggs
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-03       Impact factor: 11.205

4.  Normal myofibrillar development followed by progressive sarcomeric disruption with actin accumulations in a mouse Cfl2 knockout demonstrates requirement of cofilin-2 for muscle maintenance.

Authors:  Pankaj B Agrawal; Mugdha Joshi; Talia Savic; Zoe Chen; Alan H Beggs
Journal:  Hum Mol Genet       Date:  2012-02-17       Impact factor: 6.150

5.  Changes in cross-bridge cycling underlie muscle weakness in patients with tropomyosin 3-based myopathy.

Authors:  Coen A C Ottenheijm; Michael W Lawlor; Ger J M Stienen; Henk Granzier; Alan H Beggs
Journal:  Hum Mol Genet       Date:  2011-02-28       Impact factor: 6.150

6.  Mutations of tropomyosin 3 (TPM3) are common and associated with type 1 myofiber hypotrophy in congenital fiber type disproportion.

Authors:  Michael W Lawlor; Elizabeth T Dechene; Emily Roumm; Amelia S Geggel; Behzad Moghadaszadeh; Alan H Beggs
Journal:  Hum Mutat       Date:  2010-02       Impact factor: 4.878

7.  Clinical heterogeneity in Korean patients with nemaline myopathy.

Authors:  Ji-Man Hong; Seung-Min Kim; Il-Nam Sunwoo; Se-Hoon Kim; Tai-Seung Kim; Dong-Suk Shim; Young-Chul Choi
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

8.  Deleting exon 55 from the nebulin gene induces severe muscle weakness in a mouse model for nemaline myopathy.

Authors:  Coen A C Ottenheijm; Danielle Buck; Josine M de Winter; Claudia Ferrara; Nicoletta Piroddi; Chiara Tesi; Jeffrey R Jasper; Fady I Malik; Hui Meng; Ger J M Stienen; Alan H Beggs; Siegfried Labeit; Corrado Poggesi; Michael W Lawlor; Henk Granzier
Journal:  Brain       Date:  2013-05-28       Impact factor: 13.501

9.  Altered myofilament function depresses force generation in patients with nebulin-based nemaline myopathy (NEM2).

Authors:  Coen A C Ottenheijm; Pleuni Hooijman; Elizabeth T DeChene; Ger J Stienen; Alan H Beggs; Henk Granzier
Journal:  J Struct Biol       Date:  2009-11-26       Impact factor: 2.867

10.  Phenotypes induced by NM causing alpha-skeletal muscle actin mutants in fibroblasts, Sol 8 myoblasts and myotubes.

Authors:  Drieke Vandamme; Ellen Lambert; Davy Waterschoot; Davina Tondeleir; Joël Vandekerckhove; Laura M Machesky; Bruno Constantin; Heidi Rommelaere; Christophe Ampe
Journal:  BMC Res Notes       Date:  2009-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.